(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 37.64% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,611.96%.
Biodesix's revenue in 2026 is $80,173,000.On average, 7 Wall Street analysts forecast BDSX's revenue for 2026 to be $877,909,840, with the lowest BDSX revenue forecast at $791,351,987, and the highest BDSX revenue forecast at $979,026,596.
In 2027, BDSX is forecast to generate $1,071,710,326 in revenue, with the lowest revenue forecast at $956,671,121 and the highest revenue forecast at $1,174,497,777.